Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Breast cancer heterogeneity: a mixture of at least two main types?

× No keyword cloud information.

43 in total

1. Qualitative age interactions in breast cancer studies: mind the gap.

Authors: William F Anderson; Ismail Jatoi; Mark E Sherman
Journal: J Clin Oncol Date: 2009-10-13 Impact factor: 44.544

2. Dermcidin expression is associated with disease progression and survival among breast cancer patients.

Authors: Heather Ann Brauer; Monica D'Arcy; Tanya E Libby; Henry J Thompson; Yutaka Y Yasui; Nobuyuki Hamajima; Christopher I Li; Melissa A Troester; Paul D Lampe
Journal: Breast Cancer Res Treat Date: 2014-02-22 Impact factor: 4.872

3. Utilizing Automated Breast Cancer Detection to Identify Spatial Distributions of Tumor-Infiltrating Lymphocytes in Invasive Breast Cancer.

Authors: Han Le; Rajarsi Gupta; Le Hou; Shahira Abousamra; Danielle Fassler; Luke Torre-Healy; Richard A Moffitt; Tahsin Kurc; Dimitris Samaras; Rebecca Batiste; Tianhao Zhao; Arvind Rao; Alison L Van Dyke; Ashish Sharma; Erich Bremer; Jonas S Almeida; Joel Saltz
Journal: Am J Pathol Date: 2020-04-08 Impact factor: 4.307

Breast cancer heterogeneity: a mixture of at least two main types?

1. Qualitative age interactions in breast cancer studies: mind the gap.

2. Dermcidin expression is associated with disease progression and survival among breast cancer patients.

3. Utilizing Automated Breast Cancer Detection to Identify Spatial Distributions of Tumor-Infiltrating Lymphocytes in Invasive Breast Cancer.

4. Late Colon Involvement by Lobular Carcinoma of the Breast: A Diagnosis to Keep in Mind!

Review 5. Estrogen and progesterone in normal mammary gland development and in cancer.

6. Sample size re-estimation in a breast cancer trial.

Review 7. Genetic susceptibility to breast cancer.

8. Tracking and evaluating molecular tumor markers with cancer registry data: HER2 and breast cancer.

9. LSOSS: Detection of Cancer Outlier Differential Gene Expression.

10. Parallel routes of human carcinoma development: implications of the age-specific incidence data.